The man who acquired Sound United and founded US Health Company Masimo has been sacked by his own board, and to top that that ...

Medical-device maker said Joe Kiani, who previously informed the board of his decision to resign as chief executive, has been ...

The consensus rating for Masimo is Buy, based on 2 analyst ratings. With an average one-year price target of $167.5, there's a potential 16.14% upside.

In its upcoming report, Masimo (MASI) is predicted by Wall Street analysts to post quarterly earnings of $0.84 per share, reflecting an increase of 33.3% compared to the same period last year.

Apple has sought an injunction against health tech maker Masimo’s own smart watches, but it also netted the bare minimum for ...

Masimo filed a lawsuit against its founder and former CEO Joe Kiani and investment firm RTW Investments, accusing them of ...

Apple convinced a federal jury on Friday that health monitoring tech company Masimo’s smartwatches infringe two of its design ...

In the latest lawsuit, Apple was awarded $250 in damages – the statutory minimum, which was what the company sought in its ...

A federal jury ruled Friday that Masimo smartwatches infringed Apple patents, but Apple isn’t getting a big payday. Bloomberg ...

Masimo Corp. is suing founder Joe Kiani—who lost a takeover fight last month against Politan Capital Management LP—saying he ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

A federal jury Friday ruled that Masimo's smartwatches infringed on Apple Watch patents, but awarded Apple just $250 in ...